1/119
Last Half of Respiratory & GI
causative agent of whooping cough (pertussis)
Bordetella pertussis
transmission of whooping cough
droplet contact
incubation period of whooping cough
3 to 21 days
signs and symptoms of whooping cough
1) catarrhal stage: runny nose, 1-2 weeks (most contagious)
2) paroxysmal stage: bouts of severe coughing (paroxysm); fever usually dissipates
3) convalescent stage: numbers of bacteria are decreasing and no longer cause ongoing symptoms
catarrhal stage of whooping cough
characterized by runny nose, 1 to 2 weeks (most contagious)
paroxysmal stage of whooping cough
bouts of severe coughing (paroxysm); fever usually dissipates
convalescent stage of whooping cough
numbers of bacteria are decreasing and no longer cause ongoing symptoms
prevention of whooping cough
DTap vaccine
antibiotic treatment for contacts
vaccine does not provide lifelong immunity
many outbreaks today due to lack of vaccination or booster
epidemiology of Bordetella pertussis
endemic, peaks every 3-4 years (2-5 pre-vaccine era)
don’t know why its cyclic but high percentage of susceptible people in an infected area is believed to be important
reported monthly while majority of cases are reported between August and October
highly contagious: R0 of 12-17
R0 is avg # of secondary cases initiated by single primary case
Hx of pertussis
not an ancient disease
first reference in Europe seen in literature in 1540
Nils Rosen von Rosenstien wrote about it in France, claiming beginning in 1414
first ID as causative agent of whooping cough in 1900 by Jules Bordet and Octave Gengou in sputum from 5 yo
first isolated 6 years later from Bordet’s son using B-G media
pertussis rate of vaccination declined from
77% to 33% in Europe in 1970s
led to 1st of 3 epidemics
36 children died
decline in rate of fatality still
over 102k cases reported by the time it subsided in 1979
Loveday v Renton and the Wellcome Foundation
Susan Loveday, severely disabled 16 yo female
Wellcome Foundation
joined the defense in support of DPT vaccine
1st case in history: pharmaceutical company using legal system to solve a scientific question
Justice Stuart Smith 1988: ruled there was no evidence that the vaccine led to permanent neurological developments
some people still don’t believe that DPT is safe… T or F
T
DTap/IPV/Hib vaccine is recommended in UK against
diphtheria, tetanus, acellular pertussis, and inactivated poliomyelitis
resurgence of whooping cough linked to
waned immunity in vaccinated individuals
lessened potency of pertussis vaccines
new strains of B. pertussis lacking pertactin have been isolated in US, France, and Australia
awareness of pertussis
availability of better lab tests
Bordetella pertussis characteristics
Gram - coccobacilli
causes acute respiratory illness
major cause of childhood morbidity and mortality prior to introduction of the vaccine at the first part of the 20th century
virulence factors of Bordetella pertussis
fimbriae: function as adhesins and are highly immunogenic
filamentous hemagglutinin (FHA): located within the cell wall and plays a major role in attachment
pertactin: protein found in outer membrane that allows the organism to resist neutrophil action in the cell
pertussis toxin: causes leukocytes; inhibits the recruitment of immune cells - reduces cytokine production and impairs phagocytosis
paralysis of smooth muscle in the airway which leads to the whooping cough
causative agent of respiratory syncytial virus
respiratory syncytial virus (RSV)
transmission of RSV
droplet and direct contact via fomite
peak incidence in winter and early spring
premature babies and children 6 mo or younger are susceptible
100k children hospitalized each year in US
virulence factor of RSV
syncytia formation
prevention of RSV
passive antibody for high-risk children
what type of virus is RSV?
enveloped RNA
TB is an ancient human disease:
called the “Captain of the Men of Death” and “White Plague”
since the mid-1980s has reemerged as a serious threat
2.5 billion infected worldwide
signs and symptoms of TB
humans easily infected but quite resistant to disease development
85% TB cases contained in lungs
clinical TB forms
primary
secondary (reactivation or reinfection)
disseminated/extrapulmonary
primary TB
minimum infectious dose is about 10 bacterial cells
bacteria multiply inside macrophages
escape leads to cell-mediated attack on bacteria
Tubercle formation in lungs
neutrophils release enzymes causing necrotic caseous lesions that heal via calcification
T-cell action seen in tuberculin reaction
extrapulmonary tuberculosis
infection outside the lungs
regional lymph nodes
kidneys (renal TB)
long bones
genital tract (genital TB)
brain and meninges (tubercular meningitis)
for immunosuppressed patients and young children, these complications are often fatal
secondary (reactivation) TB
live bacteria can remain dormant, then reactivate
chronic TB: tubercles expand causing cavities in the lungs, and drain into the bronchial tubes and upper respiratory tract
severe symptoms develop: consumption:
violent coughing with greenish or bloody sputum
low-grade fever
anorexia; weight loss
extreme fatigue; night sweats
chest pain
if left untreated, 60% mortality rate
what are the severe symptoms of secondary TB
violent coughing with greenish or bloody sputum
low grade fever
anorexia; weight loss
extreme fatigue, night sweats
chest pain
causative agent of TB
mycobacterium tuberculosis
acid-fast bacillus, strict aerobe, slow-growing
mycolic acids, waxes in cell walls
resistant to drying and disinfectants
cord factor linked to virulence
M. avium infection in AIDS pts
pathogenesis and virulence of Mycobacterium TB
waxy cell wall enhances survival in environment and within macrophages
stimulates strong cell-mediated immune response, enhancing disease pathology
transmission of TB
droplets of respiratory mucous suspended in air; can survive as aerosol particles for 8 months
epidemiology of TB
can survive for 8 months in fine aerosol particles
susceptibility influenced by:
inadequate nutrition
debilitation of the immune system
poor access to medical care
lung damage
genetics
infection of poverty:
1.8 million people died from TB in 2015
60% of cases are among foreign-born persons
people who work in nursing homes, jails, or hospitals are at higher risk
culture and Dx
clinical Dx of disease relies on:
tuberculin testing
mantoux test
interferon-gamma release assays (IGRAs) performed on blood sample
done BEFORE lunch to not receive false positive
cultural isolation and antimicrobial susceptibility testing
acid-fast staining is used as a supplement to these techniques
TB prevention
limiting exposures to infectious airborne particles
patient isolation in negative-pressure rooms when a person with active TB is identified
live attenuated vaccine (BCG):
not used in US
Bovine TB bacterium
vaccinated individuals will respond positively to tuberculin test
treatment of latent TB
rifampin and rifapentine: 4 and 3 months, respectively
isoniazid: 9 months
treatment of active TB
rifampin, isoniazid, ethambutol, and pyrazinamide: 2 months
rifampin and isoniazid: either 4 or 7 months, depending on the case
biggest problem with TB therapy
noncompliance
failure to adhere to antibiotic regimen for TB results in
MDR-TB (multidrug resistant)
MDR TB
defined as being resistant to at least isoniazid and rifampin
requires treatment of 18-24 months with four to six drugs
common people who have been previously treated for TB
people with MDRTB are sicker and have higher mortality rates than those infected with non-MDR-TB
people with MDR-TB are ___________ and have higher _______________ than those infected with non-MDR-TB
sicker; mortality rate
extensively drug resistant TB (XDR-TB)
MDR-TB strains with resistance to two additional drugs
9% of MDR-TB cases worldwide
few treatment options
~70% mortality rate within months of diagnosis
reported in 117 countries
pneumonia
disease characterized by anatomical Dx
inflammatory condition of the lungs in which fluid fills the alveoli
wide variety of microorganisms can cause pneumonia
have appropriate characteristics that allow them to penetrate and survive in the lower respiratory tract
avoid phagocytosis or avoid being killed once inside macrophage
more children die of pneumonia than any other infectious disease
community acquired pneumonia causative agents
Streptococcus pneumoniae
40% of community-acquired bacterial cases
Legionella
less common, serious cause of disease
Mycoplasma pneumoniae and Chlamydophila pneumoniae
walking pneumonia
Histoplasma capsulatum
fungus that infects many people but causes a pneumonia-like disease in relatively few
Hantavirus
pneumonia can be secondary effect of influenza
CAP w/ S. pneumoniae
pneumococcus
small, Gram + flattened coccus, often appearing in pairs lined up end to end
factors that favor the ability of bacterium to cause disease
old age
the season
underlying viral respiratory disease
diabetes
chronic abuse of alcohol or narcotics
vaccination with PPSV23 or PCV13 encouraged for older adults
factors that favor ability of S. pneumoniae to cause CAP
old age
the season
underlying viral respiratory disease
diabetes
chronic abuse of alcohol or narcotics
vaccine for older adults to help with CAP via S. pneumoniae
PPSV23 or PCV13
CAP w/ Legionella pneumophila
weakly Gram -, motile bacterium ranging from coccus to filaments
widely distributed in tap water, cooling towers, spas, ponds, and other freshwater
resistant to chlorine
can live in association with free-living amoebas
released during aerosol formation and carried long distances
where can you find Legionella pneumophila?
tap water
cooling towers
spas
ponds
other fresh water
what’s special about Legionella living in water?
resistant to chlorine
can live in association with free-living amoebas
Legionella pneumophila characteristics
cut glass appearance on BCYE agar
aerobic, capnophilic
uses amino acids as its energy source
capable of multiplying within macrophages and protozoans
Mip gene
type IV secretion system
treatment of Legionella pneumophila
macrolides and flouroquinolones
causative agent of Legionnaire’s Disease and pontiac fever
Legionella spp.
clinical signs of Legionnaire’s Disease
cough
fever
chest pain
confusion
memory loss
GI distress
pneumonia with Legionnaire’s disease?
yes
incubation period of Legionnaire’s disease
3-14 days
attack rate of legionnaire’s disease
low (highest incidence rate in 55+)
organism isolation with legionnaire’s disease
possible
hospitalization from legionnaire’s disease
common
case fatality rate of legionnaire’s disease
5-40%
pontiac fever clinical signs
fever
chills
headache
fatigue
pneumonia w pontiac fever
no
incubation period for pontiac fever
1-2 days
attack rate for pontiac fever
high (affects all ages)
organism isolation for pontiac fever
no
hospitalization from pontiac fever
rare
case fatality rate with pontiac fever
none
transmission of Legionella spp/Legionnaire’s/Pontiac
inhalation of aerosols containing the pathogen
thrives in areas of higher humidity
most commonly transmitted through cooling towers, hot tubs, fountains, and found in plumbing systems, hot water tanks, etc.
Dx of Legionnaire’s Disease
positive x-ray & confirmatory tests
indirect fluorescent antibody test
culture (biopsy of lung or sputum)
urine antigen test
CAP atypical pneumonias
Mycoplasma and Chlamydophila
CAP symptoms from atypical pneumonias
symptoms do not resemble those of pneumococcal or other severe pneumonias
Mycoplasma and Chlamydophila transmission
aerosol droplets among people in confined to close living quarters
family, students, military
“walking pneumonia”
lack of acute illness in most pts
caused by Mycoplasma and Chlamydophila
Mycoplasma spp. characteristics
smallest free-living bacteria
lack cell wall, membrane contains sterols
naturally resistant to cell wall inhibiting antimicrobials
Mycoplasma spp. pathogenesis and virulence
extracellular pathogen
attached to respiratory mucosa through the adhesin protein called P1
ciliostasis occurs and normal clearance of upper airway isn’t as effective
allows for lower respiratory tract to become infected by microbes and mechanically irritated
causes persistent cough commonly seen
acts as super antigen
stimulates release of inflammatory cells and cytokines
WW distribution without seasonality
strict human pathogen
more severe disease associated with LRT infections
tracheobronchitis
atypical pneumonia (walking pneumonia)
otitis media
hemolytic anemia
myocarditis
pericarditis
CAP w/ Hantavirus causative agent
Bunyaviridae family
what type of virus is Bunyaviridae
enveloped virus
CAP w/ Hantavirus epidemiology
1993: cluster of unusual cases of severe lung edema among healthy young adults in the Four Corners area
localized outbreak in 2012 in Yoesmite
CAP via Hantavirus transmission
associated with presence of mice in proximity with humans
transmitted via airborne dust contaminated with urine, feces, or saliva of infected rodents
CAP w/ Histoplasma capsulatum
endemically distributed in all contents (except Australia)
highest incidence in eastern and central US
grows most abundantly in moist soils high in nitrogen content, esp those supplemented with bird and bat droppings
distribution determined by injecting fungal extract into the skin and monitoring for allergic rxn (similar to TB skin test)
highest incidence of CAP with Histoplasma capsulatum
eastern and Central US
where is Histoplasma capsulatum found
moist soils high in nitrogen content (esp those supplemented with bird/bat droppings)
CAP w/ Pneumocystitis (carinii) jiroveci
discovered in 1909
agent of pneumocystitis pneumonia
one of most frequent opportunistic infections in AIDS pts
likely transmitted through inhalation of spores
traditional antifungal drugs are ineffective against Pneumocystis pneumonia because of chemical makeup of organism’s cell wall
causative agent of pneumocystitis pneumonia
Pneumocystitis (carinii) jiroveci
One of the most frequent opportunistic infections in AIDS patients
Pneumocystitis (carinii) jiroveci
likely transmission of Pneumocystitis (carinii) jiroveci
inhalation of spores
CAP w/ respiratory viruses
very common causes of CAP
either residents of the upper respiratory tract or acquired through daily activities
viral pneumonias are generally mild
HAP most frequent causes
MRSA strains of S. aureus
Klebsiella pneumoniae
Enterobacter spp.
E. coli
Pseudomonas aeruginosa
Acinetobacter sp.
many are polymicrobial in origin
are sputum and tracheal swabs useful for HAP culture & Dx?
nope
for HAP, _______________________________ provide better information but are invasive
Endotracheal tube or bronchoalveolar lavage cultures
what may affect results of HAP culture & Dx
antibiotics they’re already taking
prevention and treatment of HAP
elevation of pts head to 30-45 degree angle to reduce aspiration of secretions
good preoperative education of pts about the importance of deep breathing
frequent coughing can reduce postoperative infection rates
proper care of mechanical ventilators and respiratory therapy equipment
empiric therapy should begin as soon as HAP suspected
Klebsiella pneumoniae
CAP lobar
person to person transmission
alcoholics and individuals with compromised respiratory system more susceptible
destruction of alveolar spaces, formation of cavities and blood tinged sputum are often observed
Klebsiella pneumoniae characteristics
Gram - rod
Enterobacteriaceae family
nonmotile but fimbriated
growth 12-43 C
urea hydrolysis
ferments glucose
K. pneumoniae pathogenesis and virulence
produces capsule
copious mucoidal growth on agar
produces bacteriocins
doesn’t harm E. coli
Enterobacter aerogenes… or is it?
facultative anaerobe
motile
produces a capsule
natural habitat is soil, water, food processing establishments
occasionally isolated from respiratory tract and feces
very similar to Klebsiella
aka Klebsiella aerogenes
virulence factor of Enterobacter aerogenes
produces a capsule
natural habitat of Enterobacter aerogenes
natural habitat is soil, water, and food processing establishments
occasionally isolated from respiratory tract and feces
Pseudomonas aeruginosa
Gram - rod
facultative anaerobe
respiration preferred over fermentation
motile (flagellated)
infection occurs when there is a break in the first-line defenses
5-10% of healthy people have it living inside them
ubiquitous distribution
soil, water
4 - 42 C
broad host range
animals, protists, and plants
major nosocomial pathogen
pneumonia and septicemia in immunocompromised patients (30% mortality rate)
define the broad host range of Pseudomonas aeruginosa
animals, protists, and plants
major nosocomial pathogen
pneumonia and septicemia in immunocompromised patients (30% mortality rate)